Hogan Lovells at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Hogan Lovells takes part in 3 sessions at Cell 2026 in London, its home city. Its program centres on regulation, from the changing rules for cell and gene therapies to the EU view of AI in decision-making. Specific topics include new rules on substances of human origin and how to validate AI tools safely.
| Organization | Cell 2026 Attendance |
|---|---|
Hogan Lovells London, UK | |
International law firm advising life sciences companies on regulatory, intellectual property and transactional matters. | Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? Digital biomanufacturing and AI Talk Fri Nov 13 12:05pm–12:30pm Changing Regulatory Environment For CGTs In 2027 (SoHO Regulations) Cell and gene therapy Talk Fri Nov 13 3:10pm–3:35pm Featured Session: AI In Decision-Making - EU's AI Perspective Digital biomanufacturing and AI |
Instantly find 20 buyers from Hogan Lovells
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction